Evidence record 10373 · automatically gathered

FTC Secures Major Settlement with Caremark, Resolving Antitrust Case Against Second Drug Middleman

Settlement will drive down patients’ out-of-pocket costs, increase transparency and ensure community pharmacies are treated fairly The Federal Trade Commission secured a settlement agreement with one of the nation’s largest pharmacy benefit managers (PBMs) and its affiliated entities, marking yet another important victory in the Commission’s fight to lower healthcare costs for Americans. View Press Release

Record details

Published: 14 July 2026
Source: US FTC Press Releases
Category: Policy
Topics: Healthcare · Transparency · Biotech
Retrieved: 15 July 2026

source-onlyevidence status

These records share source-supplied organisations, an exact publisher byline, automatic topics or regions. The reason is shown on every link; related does not mean supporting, agreeing with or verifying this record.

How to cite this record

ethics.ai (14 July 2026), “FTC Secures Major Settlement with Caremark, Resolving Antitrust Case Against Second Drug Middleman,” evidence record 10373, https://ethics.ai/record/10373 (originally published by US FTC Press Releases).

JSON

Use and limitations

This page is a stable index and citation surface for a source record. ethics.ai did not author the underlying report and has not independently verified every claim. Automatic topics may be imperfect. For consequential use, quote and cite the original publisher.